Rapidol Arnica Tablets
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
cGMP deviations
Cause type: cGMP deviation
Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.
What was recalled
Rapidol Arnica Tablets, Homeopathic Medicine, 100-count bottle, Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-405-99
Compare with the code on your package — it is the most precise check available.
Drug: Arnica
- Recalling firm
- Pharmadel, LLC
- NDC code
- 55758-405-99
- Origin
- DE, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0383-2025 · FDA notice
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Other Arnica recalls
See allRapidol Arnica Gel
cGMP deviations
Arnica 7 Cream
cGMP deviations
Kanjo Homeopathic Pain Relief Cream With Arnica
cGMP deviations
ZTE-1035 Formula
Out-of-specification test results obtained for identification testing based on HPTLC analysis.
Other recalls by Pharmadel, LLC
All 2025 recallsUrodel
cGMP deviations
Rapidol Arnica Gel
cGMP deviations
Kingskin
cGMP deviations
DoloEar Earache Drops
cGMP deviations
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.